Redefining Criteria to Ensure Adequate Sentinel Lymph Node Biopsy With Dual Tracer for Breast Cancer.

Xu, Li; Yang, Jiqiao; Du, Zhenggui; Liang, Faqing; Xie, Yanyan; Long, Quanyi; Chen, Jie; Zeng, Helin; Lv, Qing

Xu, Li; Yang, Jiqiao; Du, Zhenggui; Liang, Faqing; Xie, Yanyan; Long, Quanyi; Chen, Jie; Zeng, Helin; Lv, Qing.

Afiliação

Xu L; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Yang J; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Du Z; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Liang F; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Xie Y; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Long Q; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Chen J; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Zeng H; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Lv Q; Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.

Front Oncol ; 10: 588067, 2020.

Article em En | MEDLINE | ID: mdl-33344240

Palavras-chave

10% rule; breast cancer; methylene blue; radioisotope; sentinel lymph node biopsy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google